Profile	GDS3514 / 206386_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	56.9482	20
GSM325241	Patient no. 1: treated	124.852	30
GSM325242	Patient no. 9: control	34.369	12
GSM325243	Patient no. 9: treated	189.764	37
GSM325244	Patient no. 18: control	168.062	29
GSM325245	Patient no. 18: treated	109.695	23
GSM325246	Patient no. 12: control	97.9155	29
GSM325247	Patient no. 12: treated	17.1972	9
GSM325248	Patient no. 3: control	43.6019	19
GSM325249	Patient no. 3: treated	84.9444	30
GSM325250	Patient no. 7: control	61.1579	21
GSM325251	Patient no. 7: treated	113.489	32
GSM325252	Patient no. 15: control	87.3197	23
GSM325253	Patient no. 15: treated	192.469	35
GSM325254	Patient no. 4: control	166.648	35
GSM325255	Patient no. 4: treated	74.379	19
GSM325256	Patient no. 19: control	143.406	34
GSM325257	Patient no. 19: treated	20.842	10
GSM325258	Patient no. 14: control	254.003	43
GSM325259	Patient no. 14: treated	128.446	25
GSM325260	Patient no. 13: control	167.432	31
GSM325261	Patient no. 13: treated	244.994	38
GSM325262	Patient no. 17: control	134.837	31
GSM325263	Patient no. 17: treated	34.4166	11
GSM325264	Patient no. 10: control	114.707	28
GSM325265	Patient no. 10: treated	17.3627	6
GSM325266	Patient no. 5: control	75.1876	27
GSM325267	Patient no. 5: treated	48.178	22
GSM325268	Patient no. 11: control	67.5975	18
GSM325269	Patient no. 11: treated	47.7303	17
GSM325270	Patient no. 6: control	228.134	35
GSM325271	Patient no. 6: treated	65.8265	22
GSM325272	Patient no. 8: control	45.1159	14
GSM325273	Patient no. 8: treated	158.657	32
GSM325274	Patient no. 16: control	15.5656	7
GSM325275	Patient no. 16: treated	88.4374	24
GSM325276	Patient no. 2: control	44.0154	14
GSM325277	Patient no. 2: treated	5.42209	3